411 related articles for article (PubMed ID: 16970872)
1. Obsessive-compulsive disorder in Tourette syndrome.
Goodman WK; Storch EA; Geffken GR; Murphy TK
J Child Neurol; 2006 Aug; 21(8):704-14. PubMed ID: 16970872
[TBL] [Abstract][Full Text] [Related]
2. Obsessive-Compulsive disorder, Tourette's disorder, or pediatric autoimmune neuropsychiatric disorders associated with Streptococcus in an adolescent? Diagnostic and therapeutic challenges.
Gabbay V; Coffey B
J Child Adolesc Psychopharmacol; 2003; 13(3):209-12. PubMed ID: 14642008
[No Abstract] [Full Text] [Related]
3. Treatment practices in Tourette syndrome: the European perspective.
Rickards H; Cavanna AE; Worrall R
Eur J Paediatr Neurol; 2012 Jul; 16(4):361-4. PubMed ID: 22178398
[TBL] [Abstract][Full Text] [Related]
4. Tourette's disorder and related problems: a review and update.
Coffey BJ; Miguel EC; Savage CR; Rauch SL
Harv Rev Psychiatry; 1994; 2(3):121-32. PubMed ID: 9384893
[TBL] [Abstract][Full Text] [Related]
5. Adulthood outcome of tic and obsessive-compulsive symptom severity in children with Tourette syndrome.
Bloch MH; Peterson BS; Scahill L; Otka J; Katsovich L; Zhang H; Leckman JF
Arch Pediatr Adolesc Med; 2006 Jan; 160(1):65-9. PubMed ID: 16389213
[TBL] [Abstract][Full Text] [Related]
6. Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder.
March JS; Franklin ME; Leonard H; Garcia A; Moore P; Freeman J; Foa E
Biol Psychiatry; 2007 Feb; 61(3):344-7. PubMed ID: 17241830
[TBL] [Abstract][Full Text] [Related]
7. Combined pharmacotherapy for TS and OCD.
Hawkridge S; Stein DJ; Bouwer C
J Am Acad Child Adolesc Psychiatry; 1996 Jun; 35(6):703-4. PubMed ID: 8682749
[No Abstract] [Full Text] [Related]
8. [Diversity of obsessive-compulsive disorder and pharmacotherapy associated with obsessive-compulsive spectrum disorders].
Nakamae T
Seishin Shinkeigaku Zasshi; 2011; 113(10):1016-25. PubMed ID: 22187889
[TBL] [Abstract][Full Text] [Related]
9. Fluoxetine has no marked effect on tic symptoms in patients with Tourette's syndrome: a double-blind placebo-controlled study.
Scahill L; Riddle MA; King RA; Hardin MT; Rasmusson A; Makuch RW; Leckman JF
J Child Adolesc Psychopharmacol; 1997; 7(2):75-85. PubMed ID: 9334893
[TBL] [Abstract][Full Text] [Related]
10. Psychopharmacotherapy of Obsessive-Compulsive Symptoms within the Framework of Tourette Syndrome.
Rothenberger A; Roessner V
Curr Neuropharmacol; 2019; 17(8):703-709. PubMed ID: 30152283
[TBL] [Abstract][Full Text] [Related]
11. Childhood movement disorders and obsessive compulsive disorder.
Swedo SE; Leonard HL
J Clin Psychiatry; 1994 Mar; 55 Suppl():32-7. PubMed ID: 7915713
[TBL] [Abstract][Full Text] [Related]
12. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.
Bloch MH; Landeros-Weisenberger A; Kelmendi B; Coric V; Bracken MB; Leckman JF
Mol Psychiatry; 2006 Jul; 11(7):622-32. PubMed ID: 16585942
[TBL] [Abstract][Full Text] [Related]
13. Tourette's syndrome and obsessive compulsive disorder. Clinical aspects.
Steingard R; Dillon-Stout D
Psychiatr Clin North Am; 1992 Dec; 15(4):849-60. PubMed ID: 1461800
[TBL] [Abstract][Full Text] [Related]
14. Quetiapine treatment in a patient with Tourette's syndrome, obsessive-compulsive disorder and drug-induced mania.
Matur Z; Uçok A
Isr J Psychiatry Relat Sci; 2003; 40(2):150-2. PubMed ID: 14509206
[TBL] [Abstract][Full Text] [Related]
15. How to treat OCD in patients with Tourette syndrome.
Miguel EC; Shavitt RG; Ferrão YA; Brotto SA; Diniz JB
J Psychosom Res; 2003 Jul; 55(1):49-57. PubMed ID: 12842231
[TBL] [Abstract][Full Text] [Related]
16. Tic-related obsessive-compulsive disorder (OCD): phenomenology and treatment outcome in the Pediatric OCD Treatment Study II.
Conelea CA; Walther MR; Freeman JB; Garcia AM; Sapyta J; Khanna M; Franklin M
J Am Acad Child Adolesc Psychiatry; 2014 Dec; 53(12):1308-16. PubMed ID: 25457929
[TBL] [Abstract][Full Text] [Related]
17. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.
Simpson HB; Foa EB; Liebowitz MR; Huppert JD; Cahill S; Maher MJ; McLean CP; Bender J; Marcus SM; Williams MT; Weaver J; Vermes D; Van Meter PE; Rodriguez CI; Powers M; Pinto A; Imms P; Hahn CG; Campeas R
JAMA Psychiatry; 2013 Nov; 70(11):1190-9. PubMed ID: 24026523
[TBL] [Abstract][Full Text] [Related]
18. A Systematic Review of Evidence-based Treatment Strategies for Obsessive- compulsive Disorder Resistant to first-line Pharmacotherapy.
Albert U; Marazziti D; Di Salvo G; Solia F; Rosso G; Maina G
Curr Med Chem; 2018; 25(41):5647-5661. PubMed ID: 29278206
[TBL] [Abstract][Full Text] [Related]
19. Risperidone augmentation of serotonin reuptake inhibitors in obsessive-compulsive and related disorders.
Stein DJ; Bouwer C; Hawkridge S; Emsley RA
J Clin Psychiatry; 1997 Mar; 58(3):119-22. PubMed ID: 9108814
[TBL] [Abstract][Full Text] [Related]
20. Effects of tryptophan depletion on selective serotonin reuptake inhibitor-remitted patients with obsessive compulsive disorder.
Hood SD; Broyd A; Robinson H; Lee J; Hudaib AR; Hince DA
J Psychopharmacol; 2017 Dec; 31(12):1615-1623. PubMed ID: 29095069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
